SOURCE: BIOLASE Technology, Inc.

BIOLASE Technology, Inc.

April 07, 2011 09:00 ET

BIOLASE to Adopt Direct and Multi-Distributor Sales Model in Germany

IRVINE, CA--(Marketwire - April 7, 2011) - BIOLASE Technology, Inc. (NASDAQ: BLTI), the World's leading dental laser manufacturer and distributor, announced today plans to immediately expand BIOLASE Europe, GmbH to now include a direct sales force, along with service and support operations, for the German market. The increased operations will support the rapid growth of dental lasers in emerging markets in Eastern Europe and the Middle East. Located in Floss, Germany, which is centrally located approximately halfway between Munich and Prague, the existing 16,000 sq. ft. facility is entirely owned by the Company and is fully certified to manufacture and service all models of BIOLASE's lasers.

CEO Federico Pignatelli said, "Unfortunately, our sales of all-tissue lasers in Germany and several other countries under exclusive distribution arrangements have lagged other countries in Europe and were below our goals. After a thorough review, we have chosen to adopt the same type of direct and multi-distributor sales model in Germany that we recently successfully implemented in North America in September 2010. This model rapidly returned our North American operations to strong sales growth and renewed profitability. And, we expect the same to happen in Germany, historically a strong market for BIOLASE where we already have approximately 300 owners of our all-tissues lasers." 

"Germany is the World's third largest dental laser market with over 52,000 dentists, equal to one-third of the U.S. dental market," Pignatelli added. "It is the largest economy in Western Europe and is among the highest revenue-per-dental practice in the World. Our expectations are high for such a mature and promising high technology dental market."

Pignatelli also commented on BIOLASE's recent successes at the International Dental Show (IDS) in Cologne, Germany. "The introduction of our new flagship all-tissue laser system, the WaterLase® iPlus™, to the international dental community at the IDS in March exceeded all of our expectations. The positive response to its design, greatly enhanced performance and innovative features was shared by new and existing BIOLASE customers, laser luminaries, and attendees, as well as current and prospective international distributors." 

"Our booth was packed from start to finish and our distributor meeting at the show was the largest and most enthusiastic in Company history," Pignatelli added. "The international order rate for the iPlus and our wireless iLase™ five watt diode laser has temporarily exceeded our production capacity but, thankfully, we were able to ship units on a priority basis to dealers in key markets for their spring trade shows to continue the launch throughout the World."

France, Spain, Italy, England, the Netherlands, Austria, Belgium, Australia and New Zealand also will become non-exclusive distributor territories pending satisfactory performance discussions on an individual country-by-country basis. BIOLASE will continue to sell through its current distribution channels in all other international markets.

About BIOLASE Technology, Inc.
BIOLASE Technology, Inc., the World's leading Dental Laser company, is a medical technology company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment, products that are focused on technologies that advance the practice of dentistry and medicine. The Company's laser products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on laser and Waterlase dentistry, find BIOLASE at, Twitter at, and YouTube at

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

Contact Information

  • For further information, please contact:
    Jill Bertotti
    Allen & Caron